Vaccines. Antibiotics. Painkillers. Blood plasma products. The production of these vital commodities is indelibly linked to the chemistry, physics and engineering that are the pillars of our industrial process specialisation. Manufacturing and storage facilities. Piping and electrical design. Containment and cleanroom environments.
We have a long history of servicing the pharmaceutical and biotechnology industries, since 1963.
We have developed enduring relationships with many leading pharmaceutical companies, with the delivery of ongoing services and major projects for both greenfield and brownfield sites, including managing the challenges of upgrade works in operational facilities.
This includes the delivery of new facilities, such as classed cleanrooms, process design based on client IP, WFI and clean services, utilities and balance of plant services.
We regularly provide services to companies that have highly sensitive and confidential technology that requires their information to be held to the highest level of security. We pride ourselves on our ability to service multiple clients in various industry sectors while ensuring confidentiality is maintained at all levels of service delivery.
See for yourself just how well our flexible, stop-at-nothing approach
works for clients throughout the pharmaceuticals and biotechnology industries.
Lycopodium was engaged by Baxter Healthcare (Sydney) for the preparation of the Conceptual Design of the new injectable solutions Mix Room for the Toongabbie site.
CSL Seqirus is developing a new manufacturing facility on a greenfield site in Tullamarine, Melbourne, to produce influenza vaccines under the title ‘Project Banksia’ with a scheduled completion date of mid-2026. Lycopodium has been awarded the Process Mechanical and Electrical Detailed Design works for the Flu Cell Culture Manufacturing Facility, as part of the project.
Lycopodium has an extensive record of pharmaceutical facility delivery and was engaged by Pfizer (Perth) to provide engineering design services for the installation of a new Rommelag Blow-Fill-Seal (BFS) machine.
Perrigo wished to increase its capacity to manufacture flammable (mainly alcohol-based) pharmaceutical products and to upgrade the safety of their production in a purpose-built hazardous area and fire-rated room.
Lycopodium was engaged by Baxter Healthcare (Sydney) for the preparation of the Conceptual Design of the new injectable solutions Mix Room for the Toongabbie site.
CSL Seqirus is developing a new manufacturing facility on a greenfield site in Tullamarine, Melbourne, to produce influenza vaccines under the title ‘Project Banksia’ with a scheduled completion date of mid-2026. Lycopodium has been awarded the Process Mechanical and Electrical Detailed Design works for the Flu Cell Culture Manufacturing Facility, as part of the project.
Find out how you can turn our global engineering, construction and project management expertise to your commercial advantage.
